UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K/A
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (date of earliest event reported): September 30, 2007
MEDICAL
DISCOVERIES, INC
(Exact
Name of Registrant as Specified in Charter)
Utah
(State
of
Incorporation)
000-24569
|
87-0407858
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
1338
S. Foothill Drive, #266, Salt Lake
City, Utah 84108
|
84108
|
(Address
of Principal Executive
Offices)
|
(Zip
Code)
|
(801)
582-9583
(Registrant’s
Telephone Number, Including Area Code)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425).
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12).
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b)).
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c)).
Explanatory
Note
This
amended Current Report on Form 8-K/A (the “8-K/A”) is being filed in order to
file a correct copy of Exhibit 2.1, the Amendment to Asset Sale Agreement dated
September 30, 2007 among Medical Discoveries, Inc., MDI Oncology, Inc. and
Eucodis Pharmaceuticals Forschungs - und Entwicklungs GmbH. Exhibit 2.1 that
was
previously filed as an exhibit to the registrant’s Current Report on Form 8-K
filed on October 4, 2007 (the “Original 8-K”) differed from the actual Amendment
that was executed by the parties thereto. Except for the replaced exhibit,
this
8-K/A does not amend or update any other information contained in the Original
8-K.
ITEM
9.01 |
EXHIBITS |
|
|
|
|
Exhibit
No.
|
|
Description
|
2.1
|
|
Amendment
to Asset Sale Agreement dated September 30, 2007 among Medical
Discoveries, Inc., MDI Oncology, Inc. and Eucodis Pharmaceuticals
Forschungs - und Entwicklungs GmbH
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
MEDICAL
DISCOVERIES, INC. |
|
|
|
Date: October
5, 2007 |
By: |
/s/ RICHARD
PALMER |
|
Richard
Palmer |
|
President
|
EXHIBIT
INDEX
Exhibit
No.
|
|
Description
|
2.1
|
|
Amendment
to Asset Sale Agreement dated September 30, 2007 among Medical
Discoveries, Inc., MDI Oncology, Inc. and Eucodis Pharmaceuticals
Forschungs - und Entwicklungs GmbH
|